VBNKVersaBank
- Next report
- Dec 9
- Wednesday, in 27 days · time not announced yet
- EPS expected
- $0.35
- quarter ending Oct 31, 2026
- Last result
- $0.28In line
- vs $0.28 expected on Jun 3
- Stock move on it
- +4.74%
- two sessions around the report
- Price
- $24.00
- +0.97% today · $672M cap
Past and upcoming reports
2
| Dec 9, 2026 | Oct 31, 2026 | Time not announced yet | $0.35 | not yet | |
| Jun 3, 2026 | Apr 30, 2026 | Time not given | $0.28 | $0.28 | +4.74%2d |
Pre-earnings read
No pre-earnings read for this report
None for this company right now.
After the report
Jun 3, 2026 report
VersaBank beats Q1 EPS estimates by 4.4% with $0.282 reported EPS
VersaBank reported Q1 EPS of $0.282, beating estimates by 4.4%, while shares rose modestly post-earnings. Despite the EPS beat, recent revenue growth remains below sector average and trailing EPS growth is negative. The stock trades above analyst targets with a mixed valuation profile: a high trailing P/E but a cheaper forward P/E. Investors should watch upcoming Q2 guidance for confirmation of the strong EPS growth forecast.
Reported against expected
VersaBank reported EPS of $0.282 versus an estimate of $0.27, beating by 4.4%.
Guidance
No explicit guidance was provided in the payload. however, EPS next year is forecasted to grow 47.9%.
How the stock reacted
The stock price increased by 0.87% on the day of the report, trading around $19.67, above the analyst target of $19.29.
What changed
VersaBank beat Q1 EPS estimates by 4.4% with reported EPS of $0.282 versus $0.27 expected.
What the price now assumes
The 0.87% stock price rise reflects cautious optimism amid mixed fundamentals and a strong EPS growth forecast.
What it means for the business
Maintain a neutral stance. monitor Q2 guidance for confirmation of EPS growth sustainability.
The next one to three months, as we saw it then
Better case30%
Q2 guidance confirms strong EPS growth and revenue acceleration, validating valuation and driving multiple expansion.
Base case50%
EPS growth remains strong but revenue growth stays moderate. valuation remains mixed with limited multiple expansion.
Worse case20%
Q2 guidance disappoints with weaker EPS and revenue growth, pressuring valuation and causing multiple contraction.
If you hold it
Hold unless Q2 guidance misses EPS by more than 5% or revenue growth slows below 8%.
If you are watching
Add only if next-quarter guidance is reiterated or raised. avoid if guidance is cut or geopolitical risk escalates.
Scenario odds are a judgement, not measured.